INTRODUCTION
Hepatitis C virus (HCV) produces a chronic stimulation to the immune system because of its marked lymphotropism and it has been suggested to be an etiological agent of idiopathic pulmonary ¢brosis (IPF) (1) . We report, for the ¢rst time, the detection of HCV RNA in the BAL of a patient a¡ected by pulmonary ¢brosis.
CASE REPORT
An 81-year-old woman, non-smoker, complaining of a 5-year history of exertional dyspnea and a moderate dry cough, was admitted to our respiratory unit for worsening clinical status and in particular for dyspnea at rest, widespread muscle weakness, morning sti¡ness and pain in the large joints. She had been a waitress and then housewife, she has one sister a¡ected by chronic HCV hepatitis. She never su¡ered from bronchopulmonary diseases and she did not receive ¢brosis inducing therapy.
Physical examination
Poor nutritional status. The skin examination revealed purpuric lesions and peripheral edema on the legs. The large joints (hands, wrists, knees) were swollen, hot and painful, but no gross joint deformities were evident, except for a modest radial deviation at the wrist. Neither ¢nger clubbing nor subcutaneous nodules were noted. Thoracic auscultation revealed crackles at both lung bases.
The blood tests showed a peripheral leukocytosis (white blood cells/mmc=18.5 Â10
3
) and increased levels of the acute phase reactants.
A type II mixed cryoglobulinemia (Cryocrit 1%, IgMdelta binding polyclonal IgG) with hypocomplementemia (C4=18 mg%) and positive Waaler-Rose (WR) assay was detected. All the liver functional parameters were in the normal range and the autoimmune panel (ANA, ENA, ANCA) was negative.
The chest X-ray and the high-resolution computed tomography demonstrated a bilateral and peripheral thickening of bronchovasal interstitium more evident in upper and lower lobes of the right lung (reticular pattern) with subpleural honeycombing (Fig.1) .The hands X-ray did not show cartilage erosion.
The spirometry pointed out a worse restrictive pattern: VC (L) =1.18 (69.4%); RV (L)=0 .78 (65.4%); FEV 1 (L)= 1.12 (100%); FEV 1 /VC: 95%. Blood gas analysis (breathing room air): pO 2 =63.2 mmHg; pCO 2 =34.2 mmHg; pH=7.43.
The 6 -min walking test showed a reduced walking distance (234 m À57%); BORG max. 5; SatO 2 min.: 87% after the test.
The patient underwent a bronchoscopy (Pentax EB-1830T2) with bronchoalveolar lavage in the middle lobe. The bronchoscope was introduced by mouth, avoiding suction. No endobronchial lesions were detected. The procedure did not provoke bleeding of bronchial mucosa.
The recovered £uid (45 ml) was clear. Cytologic analysis of BAL showed a lymphocytic-neutrophilic alveolitis (cells/ml: 37 Â10 4 ; macrophages: 56.3%; lymphocytes: 23%; neutrophils: 19.2%; eosinophils: 0.7%) (Fig. 2) . The study of the lymphocyte subsets (Facscan, Becton Dickinson) showed a highT helper /T suppressor ratio (CD3+: 53.1%; CD3+CD4+: 36.1%; CD3+CD8+: 11.8%; CD4+/CD8+: 3.06, CD19+: 3.2%) and increased expression of activated phenotypes (CD3+HLADR+: 82%; CD3+CD25+: 7.3%). The patient had a subpopulation of double positiveT cells (CD3+CD4+CD8+) in both the peripheral blood and the BAL £uid (respectively, 6.2 and 3.2%). The BAL culture was negative.
quantitative HCV RNA analysis by b-DNA assay (Quantiplex Versant 3.0 , Bayer, Eraigny, France), HCV genotyping by HCV II Innolipa (Bayer, Eraigny, France).
Serum, bronchoalveolar lavage and saliva of the patient were analyzed. Serum anti-HCV antibodies were detected and HCV genotype was 2a/c.
For HCV RNA qualitative analysis serum, native unconcentrated BAL and saliva were submitted to nucleic acid extraction by a commercial procedure (NucliSens Isokit, bioMe Ł rieux, France). A 5 ml volume of the extracted RNA was used for RT-PCR, as described (3) .
For quantitative analysis 50 ml volume of serum and BAL were used for b-DNA assay, as reccomended by manufacturers. The viral load was expressed in International unit (IU)/ml by this quantitative test. In particular 1IU corresponds to 5.2 copies of HCV viral genome. 
HCVAND PULMONARY FIBROSIS
HCV RNA was found in serum and BAL, but not in saliva, by RT-PCR. Quantitative analysis was performed on positive samples, only. In particular, HCV RNA load in serum was 3 061600 IU/ml, whereas it was 6980 IU/ml in BAL, by b-DNA.
Treatment and clinical evolution
The patient started treatment with prednisone 25 mg/ day and hydroxychloroquine 400 mg/day for 1 month and 200 mg/day for the next 2 months. Re-evaluation of the clinical picture after 3 months of treatment showed worsening dyspnea, increased lung ¢brosis assessed by HRCT and a further decrease in lung volumes. In contrast, joint pain had improved, and the cryocrit and Waaler-Rose tests had become negative.
DISCUSSION
This is the ¢rst documented case of isolation of HCV genome in the BAL of a patient with pulmonary ¢brosis, HCV infection and type II cryoglobulinemia. The main limitation of microbiological assays of BAL is contamination of the £uid by oropharyngeal secretions or blood. We, therefore, considered that it was essential to exclude the presence of HCV in the saliva, which we did by RT-PCR, and con¢rm that there were no traces of blood in the cytological preparations of the BAL. In the past Ferri et al. (2) isolated the genome of HCV in lung biopsy specimens of a patient with desquamative interstitial pneumonia, but in that case it was not possible to exclude contamination of the tissues by blood during the biopsy procedure, with consequent carriage of the virus present in the blood.
The clinical data, the HRCT changes and the cytological pro¢le of the BAL suggest a diagnosis of ''idiopathic'' pulmonary ¢brosis associated with a non-erosive arthritis with a low titer positive rheumatoid factor, which is commonly observed in cases of HCV-related cryoglobulinemia (4).
A pathogenic relationship between IPF and HCV infection has been supported by data from published studies reporting that there is a higher frequency of anti-HCV antibodies in patients with idiopathic pulmonary ¢brosis (IPF) than in control populations (1^5), the presence of a subclinical alveolitis in patients with HCV infection without signs of lung damage (6^8) and anecdotal reports of an association between HCV, cryoglobulinemia and various forms of interstitial lung diseases (9, 10) .The hypothesis of a correlation between IPF and HCV infection seems to be further strengthened by the isolation, for the ¢rst time in a patient with lung ¢brosis, of the viral genome in the BAL by RT-PCR. In a recent paper, Idilman et al. reported the detection of HCV in the BAL of a patient with chronic hepatitis C and subclinical alveolitis but without clinical or radiological ¢ndings of interstitial lung disease (ILD) (8) . Interestingly, our patient also had a subpopulation of double positiveT cells in both the peripheral blood and in the BALF. This population, characterized by a CD4+CD8+ phenotype, has been previously described in both healthy individuals and in subjects infected by EBV or other viruses (11) .
There are various possible origins of viral RNA in BAL £uid: contamination by saliva or blood (both these possibilities were excluded in our case), passive leakage from the blood to the alveoli, transport via infected mononuclear cells or active replication in the alveolar microenvironment. The e¡ect of steroid therapy should also be considered as a possible factor facilitating isolation of the virus, as hypothesized in a study by Kuwano et al. (12) In conclusion, although it is di⁄cult to establish whether the concomitant presence of IPF and HCV infection is coincidental (both increase with age) or the manifestation of a pathogenic link, the data from this single case report seem to be consistent with the latter hypothesis.
